AVO.L
Advanced Oncotherapy plc
$1.75
%
Analyst Rating:N/A

Stock Details

CEO

Nicolas Serandour

Sector

Healthcare

Industry

Medical - Devices

Full Time Employees

174

Address

4 Tenterden Street, London, W1S 1TE

Advanced Oncotherapy plc, together with its subsidiaries, engages in the designing, assembling, and selling proton-based radiotherapy systems for treatment of cancer. It is developing Linac Image Guided Hadron Technology, a proton therapy system for treating cancer. The company also engages in the management of healthcare related properties. It has operations in the United Kingdom, Switzerland, and the United States. The company was formerly known as CareCapital Group plc and changed its name to Advanced Oncotherapy PLC in September 2012. Advanced Oncotherapy plc was founded in 1994 and is headquartered in London, the United Kingdom.

Income Statement  

Financials

Selected Year

Revenue Estimates

EPS Estimates

Net Income Estimates

Price target for Advanced Oncotherapy plc  $1.75

EPS

Revenue

Congress Tracker 

Insider Trading of Key Employees

Financial News: AVO.L